Leukemias involving reshuffling or rearrangement of the mixed lineage leukemia (MLL) gene, known as MLL-rearranged or MLL-r leukemias, account for 70 to 80 percent of acute leukemias in infants under one year old. In these blood cancers, a subset of acute myeloid and acute lymphoid leukemias (AML and ALL), the MLL gene breaks and reattaches to the wrong section … Continued
When Samantha Price’s four-year-old daughter, Shelby, was diagnosed with acute lymphoblastic leukemia (T-ALL) in October 2019, Price had so many questions about what the future held for both of them. What would the highs and lows of treatment look and feel like for Shelby, and how could she best care for her daughter throughout the … Continued
Due to COVID-19, Ava Girolimetti doesn’t know if she will be starting middle school this September in a classroom, on a computer screen, or a combination of both. But thanks to CAR T-cell therapy for acute lymphoblastic leukemia (ALL), she plans to be there cancer-free. The rising sixth grader can make this claim as one … Continued
By Ben Lepper Most people my age look at COVID-19 as a burden on their everyday lives of seeing friends, hanging out, and going to college. I see it differently. As an active cancer patient being treated for T-cell acute lymphoblastic leukemia (ALL), I am immunocompromised. This puts me at especially high risk for … Continued
Acute myeloid leukemia (AML), a blood cancer affecting both adults and children, requires more than one genetic “hit” to develop. As we age, many of us acquire a mutation that enables certain of our blood cells to multiply faster than others, forming their own distinct population. This first hit, known as “clonal hematopoiesis of indeterminate … Continued
Medically reviewed by Lewis Silverman, MD A greater understanding of the genomics of pediatric leukemia — the genetic errors and irregularities that underlie the disease — has enabled researchers to divide the disease into additional subtypes. This has improved physicians’ ability to identify patients with an increased risk of relapse and to prescribe treatments to … Continued
Leukemia is a type of cancer of the blood that develops in the bone marrow. The disease is the most common type of childhood cancer, and it typically presents in children between the ages of two and six. Still, the disease is rare in children; leukemia is most commonly seen in adults. Subtypes of … Continued
After undergoing a promising new treatment for acute lymphoblastic leukemia (ALL), Cole Malone is back to doing what he loves: playing on a flag football team with his twin brother, Michael. Cole and Michael Malone, who are 14, already know plenty about teamwork. Michael served as a perfect-match donor when Cole underwent a stem cell … Continued
Pediatric leukemia patient Emma Duffin is in remission, thanks to the stem cell transplant made possible by her brother, Alexander.
Leukemia, which usually occurs because of a mutation — or DNA change — is the most common childhood cancer. Some genetic syndromes can create a predisposition to leukemia, as well as other blood disorders.
Leukemia is a blood cancer that results when stem cells in the bone marrow produce abnormal blood cells.
Leukemia is a type of cancer that starts in early forms of white blood cells. White blood cells are cells that typically fight infections.
Pediatric leukemia is cancer of the blood and develops in the bone marrow. The bone marrow is the soft, spongy center of the long bones that produces the three major blood cells: white blood cells to fight infection; red blood cells that carry oxygen; and platelets that help the blood clot and stop bleeding. When … Continued
Like many of Dana-Farber’s youngest patients, 3-year-old Hannah Packman brought a favorite plaything to each of her Jimmy Fund Clinic visits. Lulu the doll, however, was unique because of the extra attention she received from pediatric social worker Deborah Berk, LICSW. When Hannah had a blood draw, Berk arranged for Lulu to have one as … Continued
Acute lymphoblastic leukemia (ALL) is a type of leukemia in which a group of white blood cells, called lymphocytes, are affected. Leukemia is the most common form of cancer in children, and about 80 percent of children with leukemia have acute lymphoblastic leukemia. Chimeric antigen receptor (CAR) T-cell therapy was approved in August 2017 for the … Continued
The Food and Drug Administration (FDA) announced today that a drug called CTL019 has become the first chimeric antigen receptor (CAR) T-cell therapy approved to treat a form of cancer. The decision means the drug can be used as standard therapy for the treatment of pediatric and young adult patients with B-cell acute lymphoblastic leukemia (ALL) … Continued
Ben Blaisdell was a popular 16-year-old when he started experiencing uncharacteristic chills, which led to an anemia diagnosis and, soon after, the surprising news that he had acute lymphoblastic leukemia (ALL). The two-year treatment was tough on him and his entire family, but Blaisdell says that he wouldn’t change his cancer diagnosis even if he … Continued
By all accounts, Annie McNamara was living a typical young adult’s life in 2015. The 26-year-old lived in South Boston with a good friend from college, worked in Duxbury in the retail department of Island Creek Oysters, and liked spending time with her friends and boyfriend, Dan. She wasn’t a huge fan of the gym … Continued
After Lacey Martin’s leukemia didn’t respond to initial rounds of chemotherapy and after she spent 10 weeks hospitalized for a stem cell transplant, the 11-year-old New Hampshire girl went home March 2 with an external line for medications that her mother would have to flush and clean twice a day. Lacey’s immune system and infection-fighting … Continued